Dendrite Clinical Systems and the Society for Cardiothoracic Surgery in the UK are pleased to announce the SCTS Conference News 2022 newspaper is now available to view/download. The newspaper reports a multitude of presentations from the meeting including the latest and the best information on new technologies and techniques in cardio-thoracic surgery.
Researchers led by the Clinical Research Unit at the Special Unit for Biomedical Research and Education (SUBRE), Aristotle University of Thessaloniki School of Medicine, Greece, have initiated a randomised control trial (RCT) that will compare minimally invasive extracorporeal circulation (MiECC) with conventional cardiopulmonary bypass (cCPB).
Dendrite Clinical Systems, working in close cooperation with the SCTS and several cardiac centres, has developed a series of ‘Dashboards’ that allow users to access to their unit’s surgical outcomes and compare them to national results in real-time. By uploading their data to the central Dendrite National Cardiac Surgical Registry, individual units or centres can instantly benchmark their results via an on-line database for internal consumption to assist units with their own clinical governance and for auditing purposes.
Dendrite Clinical Systems is delighted to announce the first ever report from New Zealand’s Te Rēhita Mate Ūtaetae - Breast Cancer Foundation National Register. The ground-breaking report, titled, “30,000 voices: Informing a better future for breast cancer in New Zealand,” covers 30,000 patients diagnosed from 2003 to 2019.
The European Society for Organ Transplantation (ESOT) has signed an agreement to develop a series of web-based registries on organ 
Dendrite and Queen Mary Hospital (Hong Kong) launch Asian Hypospadias Outcome Registry
Dendrite Clinical Systems and the Queen Mary Hospital in Hong Kong have launched the Asian Hypospadias Outcome Registry (AHOR), is a prospective web-based patient registry that will collect, record and analyse the treatment and outcomes of patients undergoing surgical repair.
Hypospadias is one of the most common congenital anomalies in males, in which the opening of the urethra is on the underside of the penis. The condition is typically characterised by proximal displacement of the urethral opening, penile curvature, and a ventrally deficient hooded foreskin. In about 70%, the urethral meatus is located distally on the penile shaft; this is considered a mild form that is not associated with other urogenital deformities. The remaining 30% are proximal and often more complex1. The prevalence is highest in North America, 34.2 per 10,000 births (range 6–129.8) and lowest in Asia, i.e., 0.6–69 per 10,000 births2.
“We are delighted to launch the first hypospadias registry in Asia,” said Dr Peter Walton, Managing Director of Dendrite Clinical Systems. “By collecting and recording data on procedures and outcomes, researchers from the Queen Mary Hospital will be able to determine the most effective treatment for this condition.”
The data from the registry will be used to benchmark outcomes and drive evidence-based improvements in the quality of care and outcomes of surgery. Over time the registry will report on patient demographics, procedure type, length of stay, complications and functional outcomes, as well as improvements in the patients’ quality of life.
To better understand current surgical practice and outcomes in Hong Kong, this online registry was developed by Dendrite using their “Intellect Web” software. This allows users to enter patient data online, using a range of modern html-5 compatible web browsers, without the need to install additional software or perform any complex system configurations. AHOR will initially be a Hong Kong registry, but there are plans to extend the registry to become a pan-Asian Registry.
References
- Duckett JW., Jr Hypospadias. Pediatr Rev. 1989;11:37–42
- Springer A, van den Heijkant M, Baumann S. Worldwide prevalence of hypospadias. J Pediatr Urol. 2016;12(152):e151–e157.
